All AbMole products are for research use only, cannot be used for human consumption.
Bempedoic acid (ETC-1002) mediates inhibition of a wide range of proinflammatory molecules that coincides with the modulation of AMPK and MAP kinase activities. It has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
In vitro: The phospho-ACC to total-ACC ratio increased by 25% and 60% in cells treated with 50 µM and 100 µM ETC-1002, respectively. Bempedoic acid (ETC-1002) has AMPK-activating properties in primary human MDMs.
In vivo: when mice were treated with 30 mg/kg of Bempedoic acid (ETC-1002) prior to thioglycollate administration, leukocyte influx into the peritoneal cavity was significantly reduced by 48% at 24 h (13.7 × 106/ml lavage fluid; P < 0.008) and by 61% at 72 h (1.8 × 106/ml lavage fluid; P < 0.002)
Biochem Pharmacol. 2025 Feb;232:116721.
The combination of gemcitabine and albumin-bound paclitaxel effectively inhibits de novo lipogenesis in pancreatic cancer cells by targeting the AMPK/SREBP1 pathway
Bempedoic acid (ETC-1002) purchased from AbMole
| Cell Experiment | |
|---|---|
| Cell lines | Primary rat hepatocytes and differentiated human monocyte-derived macrophages |
| Preparation method | Primary rat hepatocytes and differentiated human MDMs are treated with indicated concentrations of ETC-1002 for 12 h. Working solutions of ETC-1002 are prepared in serum-free RPMI 1640 containing 12 mM HEPES, 10,000 U/ml penicillin, and 100 μg/ml streptomycin. |
| Concentrations | 30 μM or 100 μM |
| Incubation time | 12 h |
| Animal Experiment | |
|---|---|
| Animal models | C57BL/6 male mice |
| Formulation | A disodium salt aqueous solution using 2:1 molar ratio of NaOH to ETC-1002 in water containing 0.5% CMC and 0.025% Tween with a final pH 7-8 |
| Dosages | 10 ml/kg |
| Administration | i.p. |
| Molecular Weight | 344.49 |
| Formula | C19H36O5 |
| CAS Number | 738606-46-7 |
| Solubility (25°C) | DMSO 60 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Nikolic D, et al. Atherosclerosis. ETC-1002: a future option for lipid disorders?
| Related AMPK Products |
|---|
| Aldometanib
Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. |
| SAMS
SAMS peptide is a specific substrate for the AMP-activated protein kinase (AMPK). |
| Marein
Marein has the neuroprotective effect due to a reduction of damage to mitochondria function and activation of the AMPK signal pathway. |
| Malvidin-3-O-arabinoside chloride
Malvidin-3-O-arabinoside chloride ameliorates ethyl carbamate-induced oxidative damage by stimulating AMPK-mediated autophagy. |
| AMPK activator 12
AMPK activator 12 is a potent AMPK activator and GDF15 inducer. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
